Aspergillus and Chronic Obstructive Pulmonary Disease Evolution

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Aug 23, 2018

Keywords

ClinConnect Summary

Aspergillosis disease is a growing problem. These diseases are not yet uncommon in chronic obstructive pulmonary disease patients. (COPD).

Aspergillosis disease are very difficult to be diagnosed or treated. Isolation of aspergillus in sputum of patients is not always responsible of a real disease. Need of treatment is discussed. That is why, we will conduct a prospective cohort study to evaluate aspergillus rate in respiratory samples of COPD patients (GOLD stage III or IV)

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • COPD patients GOLD stage III and IV
• Exclusion Criteria:
• • Cystic fibrosis
• • Pulmonary fibrosis
• • hematological malignancy
• • known aspergilloma
• • allergic bronchopulmonary aspergillosis